Wednesday
SESSION 26: NEW DEVELOPMENTS IN DRUG COATED BALLOONS (DCBs) AND DRUG ELUTING STENTS (DESs): UPDATES ON RANDOMIZED CONTROLLED TRIALS (RCTs) AND BTK LESION TREATMENTS WITH DCBs AND DESs
Location: Grand Ballroom East, 3rd Floor
Moderators:Joseph L. Mills, MD / John R. Laird, MD  
SESSION 26 SCHEDULE
NEW INFORMATION ON DCBs AND DESs FOR FEMPOP LESIONS: UPDATES ON RCTs
10:18 AM - 10:23 AM DCB Treatment Of Femoropopliteal Lesions Causing CLTI (From Boston Scientific) Is Cost Effective: Based On A 2-Year Study Of Patients Treated With Ranger DCBs: Advantages Of An .018 Device Often Suitable For Radial Access
  Presenter(s):Ignacio Escotto, MD  
Location: Grand Ballroom East, 3rd Floor
10:24 AM - 10:29 AM Stellarex (Philips) DCBs With Low Dose Paclitaxel Is Safe And Has Higher Patency Rates Than POBA With De Novo Or Recurrent Fempop Lesions At 5 Years In The ILLUMENATE US And European RCTs
  Presenter(s):Sean P. Lyden, MD / Marianne Brodmann, MD / Sahil A. Parikh, MD / William A. Gray, MD  
Location: Grand Ballroom East, 3rd Floor
10:30 AM - 10:35 AM 2-Year Results Of A RCT Comparing SurVeil DCBs (Surmodics) With In.Pact DCBs (Medtronic) For Treating Fempop Lesions: From the TRANSCEND Trial
  Presenter(s):Peter A. Schneider, MD  
Location: Grand Ballroom East, 3rd Floor
10:36 AM - 10:41 AM New Findings From The DRASTICO Study Comparing DESs To DCBs For Fempop Lesions: 5-Year Results With TASC A/B Lesions Versus TASC C/D Lesions
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
10:42 AM - 10:47 AM Value Of In.Pact DCBs (Medtronic) For Long Complex SFA-Pop Lesions Including ISR And CTOs: Technical Tips And Contraindications: From The Global Registry: What Is The Best Endo Treatment For These Lesions
  Presenter(s):Gunnar Tepe, MD / Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
10:48 AM - 10:53 AM Update On The Randomized Head To Head Comparison Of In.Pact (Medtronic) And Ranger (Boston Scientific) DCBs For Complex SFA Lesions: 3- And 4-Year Results Of The COMPARE RCT: Similar Results With Different Paclitaxel Dosages
  Presenter(s):Dierk Scheinert, MD / Sabine Steiner, MD  
Location: Grand Ballroom East, 3rd Floor
10:54 AM - 10:59 AM Below The Ankle Endo Interventions In 2023: Techniques, Devices And Should Balloons Be Drug Coated Or Not
  Presenter(s):Marianne Brodmann, MD  
Location: Grand Ballroom East, 3rd Floor
11:00 AM - 11:05 AM New Information On The Safety And Effectiveness Of The Cook Zilver PTX DES Based On An Updated Meta-Analysis And Global Data: When Is It The Best DES; When Is It The Best Treatment: Is Distal Microembolization A Concern
  Presenter(s):Peter A. Schneider, MD / William A. Gray, MD / Sahil A. Parikh, MD / Michael D. Dake, MD  
Location: Grand Ballroom East, 3rd Floor
11:06 AM - 11:11 AM Updated 5-Year Results Of The IMPERIAL RCT Head To Head Comparison Of The Eluvia DES (Boston Scientific) With The Zilver PTX DES (Cook): Both Are Safe And Effective: What Are The Differences
  Presenter(s):Stefan Mueller-Huelsbeck, MD / William A. Gray, MD / Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
11:12 AM - 11:18 AM Panel Discussion
NEW INFORMATION ON BTK DCBs AND DESs
11:18 AM - 11:23 AM Advances In BTK Drug Delivery Technology And DCBs: What Have We Learned From The In.Pact Deep BTK DCB Trial And New Challenges With Treating CLTI Patients
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
11:24 AM - 11:29 AM

Power Point Presentation with Synched Audio
5-Year Results From The AcoArt II BTK DCB RCT Show Safety With No Increased Mortality And Improved Patency Versus POBA To Treat BTK Lesions
  Presenter(s):Wei Guo, MD / Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
11:30 AM - 11:35 AM Orbital Atherectomy Vessel Preparation To Maximize DCB Efficacy In Calcified BTK Lesions: OPTIMIZE BTK RCT 2-Year Results
  Presenter(s):Thomas Zeller, MD  
Location: Grand Ballroom East, 3rd Floor
11:36 AM - 11:41 AM The Sirolimus DCB BTK Era Begins: The SELUTION DCB (From MedAlliance And Cordis): Why The FDA Considered It A Breakthrough Device: Results From Singapore And Europe Are Promising And Justified The Ongoing SELUTION4BTK IDE Trial: Preliminary Results
  Presenter(s):Patrick J. Geraghty, MD / George L. Adams, MD / Michael K.W. Lichtenberg, MD  
Location: Grand Ballroom East, 3rd Floor
11:42 AM - 11:47 AM Why Some BTK DCB Trials Have Not Shown Uniformly Better Results: Technical And Balloon Factors Matter
  Presenter(s):Francesco Liistro, MD  
Location: Grand Ballroom East, 3rd Floor
11:48 AM - 11:53 AM Three-Year Results For The BioMimics 3D Swirling Flow Stent Show Why It Is The Most Cost-Effective Stent Of Choice For CLTI Patients
  Presenter(s):Michael K.W. Lichtenberg, MD / Peter Gaines, MD / Amy Yip, PhD  
Location: Grand Ballroom East, 3rd Floor
11:54 AM - 12:00 PM Panel Discussion
12:00 PM - 1:35 PM Celebratory Lunch Break Visit Exhibits And Pavilions (2nd and 3rd Floors)
END OF SESSION 26
previous next